Pycnogenol reduces the need for asthma medication
Less need for rescue inhalers and more normal exhaled breath volume with pycnogenol
by Newsletter Editor
Doctors said asthma symptoms can flare when certain inflammatory molecules increase, and that Pycnogenol®, an anti-inflammatory from French maritime pine bark extract, can help reduce the need for corticosteroid medication.
In the study, 76 people with stable, controlled allergic asthma continued to take inhaled corticosteroid (ICS) medication, with or without 50 mg of Pycnogenol twice per day. After six months, six percent of the ICS-only group were able to decrease the daily dose of ICS compared to 55 percent for Pycnogenol.
Researchers saw about one in five in the ICS-only group graduate to a higher ICS dose while no one in the Pycnogenol group had to increase corticosteroids. The Pycnogenol group also had more days with normal exhaled breath volume (peak flow), less need for rescue inhalers, less need to consult a doctor, and more full nights’ sleep.
Reference: Panminerva Medica; 2011, Vol. 53, No. 3, Supplement 1, 57-64